Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page
- Check7 days agoChange DetectedA new revision tag v3.6.3 was added to the page, replacing the previous v3.6.1. This indicates an update to the page's revision history.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.6.1 is now shown instead of v3.6.0, indicating a small page template update rather than substantive changes to the study record. No study data or navigation elements appear to be altered.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now indicates enrollment is closed to new participants ('No longer looking for participants') and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change updates the Intervention/Treatment heading (from 'Intervention / Treatment') and the revision label to v3.6.0.SummaryDifference0.6%

- Check35 days agoChange DetectedThe page shows an updated revision tag (v3.5.5) replacing the previous v3.5.4, signaling a small deployment update to the page metadata rather than changes to study data.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page shows a revision label updated from v3.5.3 to v3.5.4, indicating a recent update to the page's content or metadata. This reflects a backend or content refresh rather than changes to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a refreshed content version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.